Man Group
XENE icon

Man Group’s Xenon Pharmaceuticals XENE Stock Holding History

Man Group’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
+310,617
New +$17.2M 0.03% 533
2026
Q1 		– Sell
-114,826
Closed -$5.15M – 2608
2025
Q4 		$5.15M Buy
114,826
+91,707
+397% +$3.85M 0.01% 1081
2025
Q3 		$928K Sell
23,119
-39,229
-63% -$1.38M ﹤0.01% 1699
2025
Q2 		$1.95M Buy
+62,348
New +$2.03M ﹤0.01% 1425
2024
Q2 		– Sell
-6,900
Closed -$297K – 2302
2024
Q1 		$297K Buy
+6,900
New +$317K ﹤0.01% 1935
2023
Q3 		– Hold
0
– – – 1441

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Man Group's XENE Position: Q2 2026 in Review

Man Group opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 310,617 shares worth $18.7M. The stake represents 0.03% of the portfolio and ranks #533 among its holdings. This is a return to the name: Man Group previously reported a position in XENE as recently as Q4 2025.

Man Group first reported a position in XENE in Q1 2024 and has held it in 5 quarters since. 316 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Man Group held 310,617 shares of Xenon Pharmaceuticals worth $18.7M as of Q2 2026.
  • Xenon Pharmaceuticals was a new Man Group position in Q2 2026.
  • Xenon Pharmaceuticals made up 0.03% of Man Group's portfolio in Q2 2026, its #533 holding.
  • Man Group first reported a position in Xenon Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • 316 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.